MX9101348A - Acidos piridin-2-carboxilicos sustituidos en posicion 4 o 5,procedimiento para su preparacion asi como su empleo como medicamentos - Google Patents

Acidos piridin-2-carboxilicos sustituidos en posicion 4 o 5,procedimiento para su preparacion asi como su empleo como medicamentos

Info

Publication number
MX9101348A
MX9101348A MX9101348A MX9101348A MX9101348A MX 9101348 A MX9101348 A MX 9101348A MX 9101348 A MX9101348 A MX 9101348A MX 9101348 A MX9101348 A MX 9101348A MX 9101348 A MX9101348 A MX 9101348A
Authority
MX
Mexico
Prior art keywords
piridin
medicines
substituted
procedure
preparation
Prior art date
Application number
MX9101348A
Other languages
English (en)
Inventor
Ekkehard Baader
Martin Bickel
Volkmar Gunzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of MX9101348A publication Critical patent/MX9101348A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
MX9101348A 1990-10-01 1991-09-30 Acidos piridin-2-carboxilicos sustituidos en posicion 4 o 5,procedimiento para su preparacion asi como su empleo como medicamentos MX9101348A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4030999A DE4030999A1 (de) 1990-10-01 1990-10-01 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
MX9101348A true MX9101348A (es) 1992-06-05

Family

ID=6415344

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101348A MX9101348A (es) 1990-10-01 1991-09-30 Acidos piridin-2-carboxilicos sustituidos en posicion 4 o 5,procedimiento para su preparacion asi como su empleo como medicamentos

Country Status (19)

Country Link
EP (1) EP0479178A3 (es)
JP (1) JPH072777A (es)
KR (1) KR920008000A (es)
CN (1) CN1060464A (es)
AU (1) AU8485191A (es)
BR (1) BR9104204A (es)
CA (1) CA2052509A1 (es)
CS (1) CS299091A3 (es)
DE (1) DE4030999A1 (es)
FI (1) FI914557A (es)
HU (1) HUT59101A (es)
IE (1) IE913436A1 (es)
IL (1) IL99606A0 (es)
MA (1) MA22312A1 (es)
MX (1) MX9101348A (es)
NO (1) NO913833L (es)
PL (1) PL291880A1 (es)
PT (1) PT99133A (es)
ZA (1) ZA917806B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW199147B (es) * 1991-03-18 1993-02-01 Hoechst Ag
CN108884047B (zh) * 2016-03-25 2022-03-08 沈阳三生制药有限责任公司 用于合成被芳基或杂芳基取代的5-羟基-1,7-萘啶化合物的中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
HUT59101A (en) 1992-04-28
JPH072777A (ja) 1995-01-06
EP0479178A2 (de) 1992-04-08
PT99133A (pt) 1992-08-31
CS299091A3 (en) 1992-04-15
CN1060464A (zh) 1992-04-22
PL291880A1 (en) 1992-06-26
BR9104204A (pt) 1992-06-02
AU8485191A (en) 1992-04-02
IL99606A0 (en) 1992-08-18
CA2052509A1 (en) 1992-04-02
DE4030999A1 (de) 1992-04-09
ZA917806B (en) 1992-05-27
EP0479178A3 (en) 1992-10-28
FI914557A0 (fi) 1991-09-27
IE913436A1 (en) 1992-04-08
HU913120D0 (en) 1992-01-28
NO913833L (no) 1992-04-02
NO913833D0 (no) 1991-09-30
MA22312A1 (fr) 1992-07-01
KR920008000A (ko) 1992-05-27
FI914557A (fi) 1992-04-02

Similar Documents

Publication Publication Date Title
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
MX20476A (es) Composiciones de polipropileno y procedimiento para su preparacion.
ES552896A0 (es) Procedimiento para preparar derivados de becimidazol sustituidos en posicion 5
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
AR240458A1 (es) Procedimeinto para preparar acidos 7-substituido-1-alquilo o cilcoalquilo-5,6,8-trifluor-1,4-dihidro-4-oxo-3-quinolincarboxilicos.
BR9004964A (pt) Composicao para tratamento de tecido
MX9101347A (es) Acidos piridin-2-carboxilicos sustituidos en posicion 4 o 5,procedimiento para su preparacion asi como su empleo como medicamentos
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9101348A (es) Acidos piridin-2-carboxilicos sustituidos en posicion 4 o 5,procedimiento para su preparacion asi como su empleo como medicamentos
MX9101794A (es) Compuestos de trifendioxazina y procedimiento para su preparacion
EP0499232A3 (en) 4-oxo-azetidine-2-sulfonic acids and their salts, processes for the preparation thereof and their use
MX9100779A (es) Compuestos azabiciclicos y procedimiento para su preparacion
BR8902181A (pt) Derivado de sultamsulfonamida,compostos intermediarios para o mesmo e composicao herbicida
DE69011992D1 (de) Wässerige Zusammensetzung.
MX9200120A (es) Compuestos de bipiridilo y procedimiento para su preparacion
DE69003003T2 (de) Pharmazeutische Zusammensetzung.
BR8903660A (pt) Composicao para tratamento de tecido
AR228136A1 (es) Procedimiento para producir hexahidro-pirimido(1,2-a)azepinas sustituidas en posicion 3
MX15982A (es) Compuestos hidrosolubles de ftalocianina y procedimiento para su preparacion.
AR240925A1 (es) "procedimiento para preparar el derivado de guanidinotiazol".